These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10729687)

  • 1. Why use placebos in clinical trials? A narrative review of the methodological literature.
    Vickers AJ; de Craen AJ
    J Clin Epidemiol; 2000 Feb; 53(2):157-61. PubMed ID: 10729687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quality of placebos used in randomized, controlled trials of lumbar and pelvic joint thrust manipulation-a systematic review.
    Puhl AA; Reinhart CJ; Doan JB; Vernon H
    Spine J; 2017 Mar; 17(3):445-456. PubMed ID: 27888138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenges of control groups, placebos and blinding in clinical trials of dietary interventions.
    Staudacher HM; Irving PM; Lomer MCE; Whelan K
    Proc Nutr Soc; 2017 Aug; 76(3):203-212. PubMed ID: 28629483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blinding in placebo-controlled trials.
    Ehrlich GE
    Ann Intern Med; 2001 Jun; 134(12):1150-1. PubMed ID: 11412060
    [No Abstract]   [Full Text] [Related]  

  • 5. Blinding in placebo-controlled trials.
    Prasad AS
    Ann Intern Med; 2001 Jun; 134(12):1150; discussion 1151. PubMed ID: 11412059
    [No Abstract]   [Full Text] [Related]  

  • 6. Innovation and placebos in research: a new design of clinical trial.
    Holbrook A; Goldsmith C
    Lancet; 2003 Dec; 362(9401):2036-7. PubMed ID: 14697799
    [No Abstract]   [Full Text] [Related]  

  • 7. The placebo mystique: Implications for clinical trial methodology.
    Clifford V
    J Paediatr Child Health; 2011 Jun; 47(6):361-6. PubMed ID: 21309878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of placebos for double-blind clinical trials. Experience with a phytopharmaceutical.
    Knipschild PG; Hoerr R; Oschmann R; van Rossum E; van Dongen MC
    Arzneimittelforschung; 1998 Oct; 48(10):1033-6. PubMed ID: 9825123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo controls in randomized trials of acupuncture.
    Vickers AJ
    Eval Health Prof; 2002 Dec; 25(4):421-35. PubMed ID: 12449085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.
    Howick J
    Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
    Cheon S; Park HJ; Chae Y; Lee H
    BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of using placebos for diagnosis and treatment in clinical practice.
    Gianola FJ
    JAAPA; 2009 Dec; 22(12):58-9. PubMed ID: 24887474
    [No Abstract]   [Full Text] [Related]  

  • 14. Active placebo control groups of pharmacological interventions were rarely used but merited serious consideration: a methodological overview.
    Jensen JS; Bielefeldt AØ; Hróbjartsson A
    J Clin Epidemiol; 2017 Jul; 87():35-46. PubMed ID: 28342907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of placebos in clinical trials and clinical practice.
    Kirsch I
    Can J Psychiatry; 2011 Apr; 56(4):191-2. PubMed ID: 21507274
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the placebo powerless?
    Kupers R
    N Engl J Med; 2001 Oct; 345(17):1278; author reply 1278-9. PubMed ID: 11680457
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of sham transcranial direct current stimulation for randomized, placebo-controlled clinical trials.
    Palm U; Reisinger E; Keeser D; Kuo MF; Pogarell O; Leicht G; Mulert C; Nitsche MA; Padberg F
    Brain Stimul; 2013 Jul; 6(4):690-5. PubMed ID: 23415938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The placebo response in clinical trials-the current state of play.
    Enck P; Klosterhalfen S
    Complement Ther Med; 2013 Apr; 21(2):98-101. PubMed ID: 23497810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ethical problems of the clinical placebo use].
    Engelhardt K
    Dtsch Med Wochenschr; 2004 Sep; 129(37):1939-42. PubMed ID: 15372375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.